drugset

drugset / Trial / NCT01401595

Brain Imaging and Treatment Studies of the Night Eating Syndrome

NCT01401595 ↗

Phase 3 Completed 87 enrolled University of Pennsylvania Forest Laboratories · collab

Non-randomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine the effectiveness of the anti-depressant Lexapro in the treatment of the Night Eating Syndrome.

Timeline

Start: 2009-12
Primary completion: 2011-09
Completion: 2011-09

Publications

Allison KC, Studt SK, Berkowitz RI, Hesson LA, Moore RH, Dubroff JG, Newberg A, Stunkard AJ. An open-label efficacy trial of escitalopram for night eating syndrome. Eat Behav. 2013 Apr;14(2):199-203. doi: 10.1016/j.eatbeh.2013.02.001. Epub 2013 Mar 5.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Escitalopram	Small molecule	20 mg	—

Indications